ExodusPoint Capital Management’s Syros Pharmaceuticals, Inc. Common Stock SYRS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-313,004
| Closed | -$673K | – | 2046 |
|
|
2024
Q3 | $673K | Buy |
313,004
+49,313
| +19% | +$106K | ﹤0.01% | 1033 |
|
|
2024
Q2 | $1.36M | Buy |
263,691
+108,702
| +70% | +$561K | 0.01% | 799 |
|
|
2024
Q1 | $829K | Buy |
154,989
+51,467
| +50% | +$275K | 0.01% | 891 |
|
|
2023
Q4 | $806K | Sell |
103,522
-4,615
| -4% | -$35.9K | 0.01% | 823 |
|
|
2023
Q3 | $427K | Sell |
108,137
-10,261
| -9% | -$40.5K | ﹤0.01% | 1251 |
|
|
2023
Q2 | $373K | Sell |
118,398
-3,157
| -3% | -$9.95K | ﹤0.01% | 1367 |
|
|
2023
Q1 | $325K | Buy |
121,555
+87,390
| +256% | +$234K | ﹤0.01% | 1359 |
|
|
2022
Q4 | $123K | Buy |
+34,165
| New | +$123K | ﹤0.01% | 1454 |
|
|
2021
Q4 | – | Sell |
-3,068
| Closed | -$137K | – | 2625 |
|
|
2021
Q3 | $137K | Buy |
+3,068
| New | +$137K | ﹤0.01% | 1803 |
|
|
2021
Q2 | – | Sell |
-1,078
| Closed | -$81K | – | 2820 |
|
|
2021
Q1 | $81K | Sell |
1,078
-911
| -46% | -$68.5K | ﹤0.01% | 1951 |
|
|
2020
Q4 | $216K | Buy |
+1,989
| New | +$216K | ﹤0.01% | 1622 |
|
|
2020
Q1 | – | Sell |
-3,678
| Closed | -$254K | – | 1674 |
|
|
2019
Q4 | $254K | Buy |
+3,678
| New | +$254K | ﹤0.01% | 1178 |
|